Correlation Between Medipharm Labs and C21 Investments

Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and C21 Investments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and C21 Investments into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medipharm Labs Corp and C21 Investments, you can compare the effects of market volatilities on Medipharm Labs and C21 Investments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of C21 Investments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and C21 Investments.

Diversification Opportunities for Medipharm Labs and C21 Investments

0.21

Correlation Coefficient

Medipharm Labs  C21 Investments

Modest diversification

The 3 months correlation between Medipharm and C21 is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and C21 Investments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C21 Investments and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with C21 Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C21 Investments has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and C21 Investments go up and down completely randomly.

Pair Corralation between Medipharm Labs and C21 Investments

Assuming the 90 days horizon Medipharm Labs Corp is expected to under-perform the C21 Investments. But the otc stock apears to be less risky and, when comparing its historical volatility, Medipharm Labs Corp is 1.84 times less risky than C21 Investments. The otc stock trades about -0.01 of its potential returns per unit of risk. The C21 Investments is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  26.00  in C21 Investments on September 19, 2024 and sell it today you would lose (7.00) from holding C21 Investments or give up 26.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Medipharm Labs Corp  vs.  C21 Investments

Medipharm Labs Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's forward indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

C21 Investments

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days C21 Investments has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, C21 Investments is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Medipharm Labs and C21 Investments

The main advantage of trading using opposite Medipharm Labs and C21 Investments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, C21 Investments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C21 Investments will offset losses from the drop in C21 Investments' long position.

The idea behind Medipharm Labs Corp and C21 Investments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.